Chapter 2 - Neoplasms (C00-D49)»Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)»Essential (hemorrhagic) thrombocythemia (D47.3)
D47.3
Essential (hemorrhagic) thrombocythemia
Related indications (MeSH) (1)
Thrombocythemia, Essential75 drugs (45 approved, 30 experimental)
A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.